EXPERIENCE

Bob has a nationwide practice trying cases and arguing federal and state appeals, primarily in the areas of antitrust, mass torts and consumer deception, as well as bet-the-company corporate and commercial litigations. His work spans numerous industries and businesses, including cloud computing and information technology, medical devices, pharmaceuticals and private equity. He appears in state and federal courts across the country, including currently California, Florida, New York, Texas, Delaware, North Carolina, New Jersey, Michigan and Washington. Bob has argued appeals in the Second, Third, Fifth and Eleventh Circuits, as well as many state appellate courts.

Bob regularly represents medical device manufacturer Becton Dickinson (BD) in private antitrust lawsuits. Bob was lead trial counsel for BD in a jury trial in Tyler, Texas involving antitrust and consumer deception claims, where he secured a defense verdict on 11 of 12 counts and then won the appeal in the Fifth Circuit on the 12^th count for attempted monopolization by deception. Bob also led the Paul, Weiss team in the complete dismissal, with prejudice, of an antitrust class action against BD in which a putative class of all U.S. hospital and healthcare providers alleged conspiracy with the distributors of its products to inflate the prices of syringes and IV catheters by excluding competitors from the market.

Most recently, Bob was trial counsel for medical device manufacturer Bard in an antitrust jury trial in the U.S. District Court for the Northern District of New York, where our team helped secure a complete defense verdict rejecting the plaintiff’s $450 million damages claim.

Bob represents Uber in thousands of tort lawsuits in California and around the country involving the Uber ridesharing app.

He also represents IBM in trade secret and unfair competition lawsuits and government investigations, and is IBM’s lead trial counsel in several nine-figure commercial litigations. Other significant clients include Novo Nordisk (the world’s largest diabetes care company), Revlon (the cosmetics company), and Roark Capital Group (the Atlanta-based private equity firm). 

Bob also defends product liability and deception lawsuits in several industries. His representations have included:

• Mitsubishi Motors Corp. in investigations and litigations related to allegedly defective airbags.
• Boeing against design defect claims in the multi-billion dollar property damage lawsuits arising from the destruction of the World Trade Center on 9/11.
• Revlon in product liability lawsuits involving allegations that certain cosmetics contain cancer-causing agents.
• Becton Dickinson in product defect class actions and individual suits claiming fatal injuries to healthcare workers.
• Take-Two Interactive in dismissing wrongful death and strict liability claims against the creator of the Grand Theft Auto video game.
• Roark Capital Group in multi-plaintiff consumer deception and personal injury lawsuits in state courts in California, Florida, New Jersey and many other states.
• FieldTurf in product defect and consumer fraud class actions and related investigations.

In addition to his commercial practice, Bob regularly litigates voting rights cases and Constitutional lawsuits involving gerrymandering, one-person/one-vote, and voter suppression. Bob serves as the Co-Chair of the Board of the Brennan Center for Justice at New York University School of Law.